Our busy Media and PR Team provide journalists with the most
up-to-date and precise information on all aspects of prostate
cancer, as quickly as possible. We deliver expert responses to the
latest developments in prostate cancer research, as well as facts,
figures and spokespeople to guide you through the issues
surrounding the disease.
We also have access to around 150 people across the UK who have
been affected by prostate cancer, and are willing to share their
experiences with the media - our Media Talkers scheme.
In the Media Centre, you will find all our latest news releases
and comments, as well as the resources you need to shape an
article, including facts, statistics and profiles of our spokespeople. If you do need
any further information, you can also find the contact
details for the Media and PR Team who will be able to
Please note that the Media Centre is a tool for journalists. For
all other enquiries, please contact the Prostate Cancer UK
switchboard on 020 8222 7622.
Enzalutamide, one of the few treatments shown to extend the lives of men with advanced prostate cancer, has been provisionally approved for use on the NHS in England and Wales, NICE have announced today (Friday 18 October 2013). A decision which could mean extra months of life to countless men.
A shocking new figure released in Black History Month by the health charity Prostate Cancer UK reveals that one in every four Black men in the UK will be diagnosed with prostate cancer at some point in his lifetime*. That’s double the overall 1-in-8 cradle-to-grave risk faced by all men in the UK.
Prostate Cancer UK calls for greater action to create a transparent and open system, with patients at its heart.
Comedy legend Billy Connolly has revealed that he has been given the all clear by doctors after being successfully treated for prostate cancer. The 70 year old Scottish comedian announced last month that he had been diagnosed with the early stages of the disease and has since undergone a surgical operation in America.